Measuring the change in R&D efficiency of the Japanese pharmaceutical industry
This paper presents a data envelopment analysis (DEA)/Malmquist index methodology for measuring the change in R&D efficiency at both firm and industry levels. Letting each of ten firms in each year be a separate decision-making unit, and employing one input and three outputs in a DEA case of R&D activity input-output lag, we measure "total factor R&D efficiency" change of Japanese pharmaceutical firms for decade 1983-1992 as defined by the period of R&D input. Decomposing Malmquist index into catch-up and frontier shift components and using "cumulative indices" proposed in this study, we evaluate R&D efficiency change for each firm and empirically show that R&D efficiency of Japanese pharmaceutical industry has almost monotonically gotten worse throughout the study decade.
When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:37:y:2008:i:10:p:1829-1836. See general information about how to correct material in RePEc.
If references are entirely missing, you can add them using this form.